
Sign up to save your podcasts
Or


Plus: Boeing has resumed production across its airplane programs, including the 737. The European Union’s drug regulator said it would review a potential link between Novo Nordisk’s diabetes drug, Ozempic, and a rare eye condition. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.2
652652 ratings
Plus: Boeing has resumed production across its airplane programs, including the 737. The European Union’s drug regulator said it would review a potential link between Novo Nordisk’s diabetes drug, Ozempic, and a rare eye condition. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,843 Listeners

1,732 Listeners

4,391 Listeners

411 Listeners

436 Listeners

1,655 Listeners

1,446 Listeners

1,045 Listeners

1,316 Listeners

6,135 Listeners

1,582 Listeners

211 Listeners

1,323 Listeners

585 Listeners

152 Listeners

87 Listeners

84 Listeners

149 Listeners